The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Transient Abnormal Myelopoiesis

Self-Limited Preleukemic Disorder of Down Syndrome Neonates

Written by: Saygı Hospital Health Guide Editorial Board
Published:

This content is for general information; please consult your physician for diagnosis and treatment.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Transient Abnormal Myelopoiesis?

A clonal myeloid proliferation arising in fetal liver of neonates with constitutional trisomy 21

Driven by acquired truncating mutations in the GATA1 transcription factor gene

Characterized by circulating megakaryoblasts that resemble acute megakaryoblastic leukemia

Most cases resolve spontaneously within the first 3 months of life

Approximately 20% of survivors progress to myeloid leukemia of Down syndrome by age 4

Symptoms

Hepatosplenomegaly with prominent abdominal distension in newborns
Pleural and pericardial effusions in severe presentations
Petechiae, bruising, and bleeding from thrombocytopenia
Hyperleukocytosis with circulating blasts on peripheral blood smear
Asymptomatic in approximately 50% of affected neonates

Risk Factors

Constitutional trisomy 21 (Down syndrome) is the universal predisposing factor
Approximately 10% of Down syndrome neonates develop overt TAM
Mosaic Down syndrome with somatic GATA1 mutations represents an important subset
Male and female newborns are affected equally
No environmental or perinatal risk factors are clearly established

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Any Down syndrome newborn with abnormal complete blood count or peripheral blasts
  • Hepatosplenomegaly, jaundice, or liver dysfunction in the first weeks of life
  • Hydrops fetalis or fetal effusions on prenatal ultrasound
  • Disseminated intravascular coagulation or hemorrhagic complications
  • Persistent blasts beyond 3 months of life suggesting progression

Treatment Methods

01
Watchful waiting with serial blood counts in asymptomatic infants
02
Low-dose cytarabine for life-threatening organ dysfunction or hyperleukocytosis
03
Exchange transfusion or leukapheresis for severe leukostasis
04
Treatment of liver fibrosis, effusions, and coagulopathy as supportive measures
05
Long-term hematology follow-up to monitor for progression to myeloid leukemia

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.